Embedding Implementation Science in Clinical Trials: A Framework for Academic-Life Science Partnerships

Area of Science:

• Implementation Science
• Translational Research
• Health Services Research

Background:

• Academic implementation science in the USA traditionally focuses on late-stage research.
• Limited early engagement with life science partners misses opportunities to address real-world implementation challenges proactively.
• Early integration of implementation science into drug development can improve therapy uptake.

Purpose of the Study:

• To explore how implementation scientists can better support new therapy development and delivery with life science partners.
• To propose a framework for collaboration between implementation scientists and life science partners.
• To highlight the benefits of early integration throughout the clinical trial lifecycle.

Main Methods:

• Conceptual framework development for collaboration.
• Analysis of opportunities for early integration in clinical trials.
• Discussion of implementation science's role in strengthening trial design and informing stakeholder selection.

Main Results:

• Early integration identifies healthcare system constraints, clinician barriers, and patient acceptability issues.
• Implementation science can enhance trial design, site selection, and readiness for real-world uptake.
• Alignment with pharmaceutical sponsors' priorities provides actionable insights for clinical and commercial success.

Conclusions:

• Strengthened partnerships between implementation scientists and life science partners, established early, can accelerate the translation of therapies into routine care.
• Early collaboration improves return on investment and reduces the time to clinical impact.
• Proactive implementation science integration enhances the likelihood of successful therapy adoption and sustainment.